Literature DB >> 24306178

Individuals with coronary artery disease at a young age and features of the metabolic syndrome have an increased prothrombotic potential.

M G M Kok, J C M Meijers, S-J Pinto-Sietsma1.   

Abstract

The relation between coagulation and atherosclerosis has been extensively described, pointing towards a hypercoagulable state in patients with atherosclerosis, especially in young individuals. However, not all studies were conclusive. It is known that the metabolic syndrome (MetS), a risk factor for coronary artery disease (CAD), is related to a higher incidence of thrombo-embolic events. We hypothesised that individuals with CAD at a young age and MetS have an increased prothrombotic potential. It was the study objective to analyse the endogenous thrombin potential (ETP) and related thrombin generation parameters in patients with CAD before the age of 51 in men and 56 in women with and without MetS features and their healthy first-degree relatives. In this case-control study we included 118 CAD patients and 50 first-degree relatives (controls). Parameters of thrombin generation were obtained with calibrated automated thrombinography. An adjusted general linear model (GLM) showed a positive association between the peak thrombin levels and the presence of CAD at a young age. Based on the NCEP criteria we divided our patient group in CAD patients with and without MetS, and compared them to the controls without MetS. We showed that CAD patients with MetS have increased ETP levels, both in comparison with healthy first-degree relatives and with CAD patients without MetS. There were no differences in ETP between patients without MetS and healthy controls. In conclusion, this study shows that individuals with CAD at a young age and MetS features have an increased prothrombotic potential, compared to CAD patients without MetS.

Entities:  

Keywords:  Atherosclerosis; hypercoagulability; metabolic disorders; thrombin

Mesh:

Substances:

Year:  2013        PMID: 24306178     DOI: 10.1160/TH13-07-0587

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  1 in total

Review 1.  Adiponectin: an adipokine with protective features against metabolic syndrome.

Authors:  Maryam Esfahani; Ahmad Movahedian; Mostafa Baranchi; Mohammad Taghi Goodarzi
Journal:  Iran J Basic Med Sci       Date:  2015-05       Impact factor: 2.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.